Xitiz Chamling is an assistant professor of ophthalmology at Johns Hopkins University School of Medicine. From vision research to the pursuit of multiple sclerosis treatments, his philosophy of science centers human-based systems to study the neuroprotective layer called myelin, which surrounds and insulates nerves cells.

In this episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with Chamling to learn more about his latest work combining stem cell and CRISPR-Cas9 technologies to break away from conventional high throughput drug screening platforms that rely on rodent cells.

To learn more about Chamling's research, please check out this article.